A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)
Published Online: 2013-10-30
Journal: Molecular Imaging and Biology•Publisher: Springer Science and Business Media LLC
Authors: Brenda F. Kurland•David A. Mankoff•Erin K. Schubert•Hannah M. Linden•Janet F. Eary•Jeanne M. Link•Jennifer M. Specht•Lalitha K. Shankar•Lanell M. Peterson•Peggy Porter•V.K. Gadi
